Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies

Spero Cataland, MD, Marie Scully, Flora Peyvandi, MD PhD, Paul Knoebl, MD, Johanna A. Kremer Hovinga, MD Prof, Paul Coppo, MD PhD, Ara Metjian, MD, Javier De La Rubia, Katerina Pavenski, MD, Hilde De Winter, MD, Filip Callewaert

Blood (2019) 134 (Supplement_1): 4908.

https://doi.org/10.1182/blood-2019-123124

Published: 2019

Journal Articles

Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study

Spero R Cataland, MD, Marie Scully, MD MRCP, FRCPath, Flora Peyvandi, MD PhD, Paul Coppo, MD PhD, Paul Knöbl, MD PhD, Johanna A. Kremer Hovinga, MD Prof, Ara Metjian, MD, Javier De La Rubia, MD, Katerina Pavenski, MD, Jessica Minkue, Rui Passos Sousa, MD MSc, Filip Callewaert, PhD, Hilde De Winter, MD

Blood (2018) 132 (Supplement 1): 1142.

https://doi.org/10.1182/blood-2018-99-112179

Published: 2018

Journal Articles

Ten Years of Cerebral Venous Thrombosis (CVT) in Melbourne, Australia: Male Gender and Presence of Myeloproliferative Neoplasm Is Associated with Thrombotic Recurrence in Unprovoked Events

Hui Yin Lim, MBBS, Cheryl Ng, Carole L. Smith, MBBS,FRCPA,FRACP,MD, Geoffrey Donnan, MBBS, FRACP, Harshal Nandurkar, PhD FRACP, FRCPA, Prahlad Ho, MBBS, FRACP, FRCPA

Blood (2015) 126 (23): 4468.

https://doi.org/10.1182/blood.V126.23.4468.4468

Published: 2015

Journal Articles

Soluble Epoxide Hydrolase As An Anti-Inflammatory Target Of The Thrombolytic Stroke Drug Candidate Smtp-7

Eriko Suzuki, PhD, Naoki Matsumoto, Keita Shibata, PhD, Terumasa Hashimoto, MD, PhD, Kazuo Honda, PhD, Keiji Hasumi, PhD

Blood (2013) 122 (21): 2336.

https://doi.org/10.1182/blood.V122.21.2336.2336

Published: 2013

Journal Articles

Prevalence of Risk Factors for VTE In Hospitalized Medical and Surgical Patients. Data From the Comparison of Methods for Thromboembolic Risk Assessment with Clinical Perceptions and AwareneSS In Real Life Surgical and Medical Patients (COMPASS) Study

Grigoris T Gerotziafas, Miltos Chrysanthidis, Reda Isaad, Hela Baccouche, Chrysoula Papageorgiou, Brigitte Thiolier, Alex C Spyropoulos, MD, Vassiliki Galea, Asterios Katsamouris, Dimitris Kiskinis, Ismail Elalamy

Blood (2010) 116 (21): 3337.

https://doi.org/10.1182/blood.V116.21.3337.3337

Published: 2010

Journal Articles

Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.

Alexander T. Cohen, Raza Alikhan, Juan I. Arcelus, Jean-François Bergmann, Sylvia Haas, Geno J. Merli, Alex C. Spyropoulos, Victor F. Tapson, Alexander G.G. Turpie

Blood (2004) 104 (11): 1786.

https://doi.org/10.1182/blood.V104.11.1786.1786

Published: 2004

NARROW

Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies

Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study

Ten Years of Cerebral Venous Thrombosis (CVT) in Melbourne, Australia: Male Gender and Presence of Myeloproliferative Neoplasm Is Associated with Thrombotic Recurrence in Unprovoked Events

Soluble Epoxide Hydrolase As An Anti-Inflammatory Target Of The Thrombolytic Stroke Drug Candidate Smtp-7

Prevalence of Risk Factors for VTE In Hospitalized Medical and Surgical Patients. Data From the Comparison of Methods for Thromboembolic Risk Assessment with Clinical Perceptions and AwareneSS In Real Life Surgical and Medical Patients (COMPASS) Study

Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.

Email alerts

ASH Publications

American Society of Hematology

Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies

Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study

Ten Years of Cerebral Venous Thrombosis (CVT) in Melbourne, Australia: Male Gender and Presence of Myeloproliferative Neoplasm Is Associated with Thrombotic Recurrence in Unprovoked Events

Soluble Epoxide Hydrolase As An Anti-Inflammatory Target Of The Thrombolytic Stroke Drug Candidate Smtp-7

Prevalence of Risk Factors for VTE In Hospitalized Medical and Surgical Patients. Data From the Comparison of Methods for Thromboembolic Risk Assessment with Clinical Perceptions and AwareneSS In Real Life Surgical and Medical Patients (COMPASS) Study

Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only